Walsh, D. J.

NCCTG phase II trial of CCI-779 in recurrent glioblastoma multiforme (GBM)

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 1503-1503

10.1200/jco.2004.22.90140.1503